IShares Medical ETF Top Insiders
| IHI Etf | USD 60.35 0.05 0.08% |
IShares Medical employs about 15 people. The company is managed by 15 executives with a total tenure of roughly 251 years, averaging almost 16.0 years of service per executive, having 1.0 employees per reported executive. Assessment of IShares Medical's management performance can provide insight into the Etf performance.
| Geoffrey Flynn President Chief Operating Officer, Executive Vice President |
| Robert Silver Executive Independent Trustee |
IShares |
IShares Medical Workforce Comparison
iShares Medical Devices is considered the top ETF in number of employees as compared to similar ETFs. The total workforce of Health category is currently estimated at about 30.0. IShares Medical totals roughly 15.0 in number of employees claiming about 50% of all ETFs under Health category.
IShares Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IShares Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on IShares Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, IShares Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Haas David R over three months ago Disposition of 828 shares by Haas David R of IShares Medical at 18.125 subject to Rule 16b-3 | ||
Jarrett Keith B over six months ago Acquisition by Jarrett Keith B of 300 shares of IShares US at 15.94 subject to Rule 16b-3 |
IShares Medical Notable Stakeholders
An IShares Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IShares Medical often face trade-offs trying to please all of them. IShares Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IShares Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| George Parker | Independent Chairman of the Board of Trustees | Profile | |
| Geoffrey Flynn | Chief Operating Officer, Executive Vice President | Profile | |
| Matt Tucker | Vice President | Profile | |
| Michael Latham | President Trustee | Profile | |
| Amy Schioldager | Executive Vice President | Profile | |
| Ira Shapiro | Vice President Chief Legal Officer | Profile | |
| Jack Gee | Chief Financial Officer, Treasurer | Profile | |
| Robert Silver | Independent Trustee | Profile | |
| John Kerrigan | Independent Trustee | Profile | |
| Madhav Rajan | Independent Trustee | Profile | |
| Cecilia Herbert | Independent Trustee | Profile | |
| Charles Hurty | Independent Trustee | Profile | |
| Eilleen Clavere | Secretary | Profile | |
| John Martinez | Independent Trustee | Profile | |
| Robert Kapito | Trustee | Profile |
About IShares Medical Management Performance
The success or failure of an entity such as iShares Medical Devices often depends on how effective the management is. IShares Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IShares management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IShares management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The fund will invest at least 80 percent of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. US Medical is traded on NYSEARCA Exchange in the United States.
The data published in IShares Medical's official financial statements typically reflect IShares Medical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving IShares Medical's quantitative information. For example, before you start analyzing numbers published by IShares accountants, it's essential to understand IShares Medical's liquidity, profitability, and earnings quality within the context of the iShares space in which it operates.
When determining whether iShares Medical Devices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Medical Devices Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Medical Devices Etf: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Medical Devices. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.